Sort
16,300 grants matching “fatty liver disease”
Notch, Type 2 Diabetes and NAFLD
$523,795Utpal Pajvani · Columbia University Health Sciences · R01 · FY2021 · DK
Notch, Type 2 Diabetes and NAFLD
$523,795Utpal Pajvani · Columbia University Health Sciences · R01 · FY2023 · DK
Notch, Type 2 Diabetes and NAFLD
$523,795Utpal Pajvani · Columbia University Health Sciences · R01 · FY2022 · DK
Type 2 diabetes in Hispanic adolescents
$523,787Michael I Goran · University Of Southern California · R01 · FY2008 · DK
Inflammation and hepatic lipid metabolism
$523,764Alan R. Saltiel · University Of California, San Diego · R01 · FY2020 · DK
Accurate Detection of Early-Stage Pancreatic Tumors using Artificial Intelligence Analysis of Abdominal Computed Tomography Scans
$523,670Touseef Ahmad Qureshi · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Liver Parametric PET
$523,648Guobao Wang · University Of California At Davis · R01 · FY2023 · DK
Regulating energy expenditure in adipose tissue
$523,296Alan R. Saltiel · University Of California, San Diego · R01 · FY2024 · DK
Project 2: Gut microbial choline metabolites in cardiometabolic disease
$523,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · HL
Project 2: Gut microbial choline metabolites in cardiometabolic disease
$523,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · HL
Project 2: Gut microbial choline metabolites in cardiometabolic disease
$523,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL
Project 2: Gut microbial choline metabolites in cardiometabolic disease
$523,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · HL
NF-KB, Inflammation and Vascular Remodeling
$523,234Steven E Shoelson · Beth Israel Deaconess Medical Center · P50 · FY2007 · HL
Mitochondrial Aging and Reprogramming
$523,066Shoukhrat M Mitalipov · Oregon Health & Science University · R56 · FY2015 · AG
Sphingolipids in alcoholic liver disease
$523,062Huiping Rose Zhou · Virginia Commonwealth University · R01 · FY2023 · AA
Sphingolipids in alcoholic liver disease
$523,062Huiping Rose Zhou · Virginia Commonwealth University · R01 · FY2024 · AA
Sphingolipids in alcoholic liver disease
$523,062Huiping Rose Zhou · Virginia Commonwealth University · R01 · FY2025 · AA
Mechanisms of Insulin Resistance in Man
$522,996Robert A. Rizza · Mayo Clinic Rochester · R01 · FY2007 · DK
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$522,913Shruti H Mehta · Johns Hopkins University · R01 · FY2015 · DA
Host-Microbiota-Diet Interactions in Metabolic Syndrome and IBD
$522,819Andrew T Gewirtz · Georgia State University · R01 · FY2023 · DK
Host-Microbiota-Diet Interactions in Metabolic Syndrome and IBD
$522,819Andrew T Gewirtz · Georgia State University · R01 · FY2022 · DK
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
$522,817Russell Paul Goodman · Massachusetts General Hospital · R01 · FY2024 · DK
Hyperhomocysteinemia and HDL Metabolism
$522,739Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2014 · HL
Systems Biology of Cognitive Decline in Older Adults with HIV Infection
$522,673Dana H. Gabuzda · Dana-Farber Cancer Inst · R01 · FY2015 · MH
Systems Biology of Cognitive Decline in Older Adults with HIV Infection
$522,673Dana H. Gabuzda · Dana-Farber Cancer Inst · R01 · FY2014 · MH